These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36599437)

  • 1. [Chinese consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases (2023)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):19-25. PubMed ID: 36599437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experts' consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases in China (2022)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2022 May; 43(5):359-364. PubMed ID: 35680591
    [No Abstract]   [Full Text] [Related]  

  • 3. Adherence to Sars-CoV2 vaccination in hematological patients.
    Narinx J; Houbiers M; Seidel L; Beguin Y
    Front Immunol; 2022; 13():994311. PubMed ID: 36300128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection.
    Baimukhamedov C; Makhmudov S; Botabekova A
    Int J Rheum Dis; 2021 Nov; 24(11):1440-1441. PubMed ID: 34585843
    [No Abstract]   [Full Text] [Related]  

  • 6. Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia.
    Pfrepper C; Holstein K; Königs C; Heller C; Krause M; Olivieri M; Bidlingmaier C; Sigl-Kraetzig M; Wendisch J; Halimeh S; Horneff S; Richter H; Wieland I; Klamroth R; Oldenburg J; Tiede A;
    Hamostaseologie; 2021 Jun; 41(3):190-196. PubMed ID: 33860513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of hematological patients concomitant with COVID-19.
    Zhou X; Wang G; Chen L; Meng F; Huang L; Huang L; Wang N; Li T; Cao Y; Zhou J
    Cancer Sci; 2020 Sep; 111(9):3379-3385. PubMed ID: 32619034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viewpoint of the European Pediatric Societies over Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Children Younger Than Age 12 Years Amid Return to School and the Surging Virus Variants.
    Pettoello-Mantovani M; Carrasco-Sanz A; Huss G; Mestrovic J; Vural M; Pop TL; Ferrara P; Somekh E; Mujkic A; Hoey H; Namazova-Baranova L
    J Pediatr; 2021 Dec; 239():250-251.e2. PubMed ID: 34536493
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 vaccination for patients with epilepsy: A Chinese expert consensus.
    Liu X; Wang Q; Ren L; Fang X; He Z; Ding J; Wang K; Xu H; Zhang H; Song Y; Lu Q; Sun M; Han X; Cao L; Lin W; Li X; Zhang Q; Ding Y; Wang F; Wang T; Wang J; Liu X; Wu Y; Chen Y; Feng Z; Wang S; Wang X; Guan Y; Xie X; Huang H; Zhang M; Wang X; Hong Z; Jiang W; Han Y; Deng Y; Zhao J; Liao J; Wang Y; Lian Y
    Epilepsy Behav; 2023 Oct; 147():109387. PubMed ID: 37625346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 12. Patterns of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Among 1.6 Million Blood Donors: Impact of Vaccination, United States, December 2020-June 2021.
    Dodd RY; Notari EP; Brodsky JP; Foster GA; Xu M; Saá P; Stramer SL
    J Infect Dis; 2022 Jan; 225(1):5-9. PubMed ID: 34626465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination for SARS-CoV-2 in Hematological Patients.
    Riccardi N; Falcone M; Yahav D
    Acta Haematol; 2022; 145(3):257-266. PubMed ID: 35220303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.
    Thakur KT; Epstein S; Bilski A; Balbi A; Boehme AK; Brannagan TH; Wesley SF; Riley CS
    Neurology; 2021 Oct; 97(16):767-775. PubMed ID: 34475124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
    Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
    Piñana JL; Vázquez L; Martino R; de la Cámara R; Sureda A; Rodríguez-Veiga R; Garrido A; Sierra J; Ribera JM; Torrent A; Mateos MV; de la Rubia J; Tormo M; Díez-Campelo M; García-Gutiérrez V; Álvarez-Larrán A; Sancho JM; MartínGarcía-Sancho A; Yañez L; Pérez Simón JA; Barba P; Abrisqueta P; Álvarez-Twose I; Bonanad S; Lecumberri R; Ruiz-Camps I; Navarro D; Hernández-Rivas JÁ; Cedillo Á; García-Sanz R; Bosch F
    Leuk Lymphoma; 2022 Mar; 63(3):538-550. PubMed ID: 34668835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases?
    Shi Y; Guo M; Yang W; Liu S; Zhu B; Yang L; Yang C; Liu C
    Expert Rev Vaccines; 2021 Apr; 20(4):375-383. PubMed ID: 33787439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.
    Piñana JL; López-Corral L; Martino R; Vazquez L; Pérez A; Martin-Martin G; Gago B; Sanz-Linares G; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; Corona M; Marcos-Corrales S; Tormo M; Hernández-Rivas JÁ; Montoro J; Rodriguez-Fernandez A; Risco-Gálvez I; Rodríguez-Belenguer P; Hernandez-Boluda JC; García-Cadenas I; Ruiz-García M; Muñoz-Bellido JL; Solano C; Cedillo Á; Sureda A; Navarro D;
    J Hematol Oncol; 2022 May; 15(1):54. PubMed ID: 35526045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases.
    Almeida Neto JB; Arce IL; Figueiredo VLP; Vicari P
    Einstein (Sao Paulo); 2023; 21():eAO0089. PubMed ID: 36946824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.